Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines
- 10 February 2006
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 340 (2), 469-475
- https://doi.org/10.1016/j.bbrc.2005.12.025
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Mutations of the BRAF gene in human cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- The Hallmarks of CancerCell, 2000